Related Experiment Videos
[Prophylaxis and treatment of adynamic bone]
Hiroaki Ogata1, Masahiro Yamamoto, Susumu Taguchi
1Internal Medicine, Showa University Northern Yokohama Hospital.
Clinical Calcium
|December 4, 2004
Summary
Adynamic bone disease (ABD) involves calcium overload and vitamin D (VD) issues. Reducing calcium load with sevelamer hydrochloride and managing VD can prevent and treat ABD.
Area of Science:
- Nephrology
- Bone Metabolism
- Pharmacology
Background:
- Adynamic bone disease (ABD) pathogenesis involves calcium overload, vitamin D (VD) metabolism, parathyroid hormone (PTH) fragments, and bone metabolism regulation.
- Increased calcium (Ca) overload is a critical factor in ABD development.
Purpose of the Study:
- To investigate the role of calcium overload in adynamic bone disease.
- To evaluate the potential of sevelamer hydrochloride and vitamin D administration in managing ABD.
Main Methods:
- Review of pathogenesis factors for adynamic bone disease.
- Analysis of the impact of calcium load on bone metabolism.
Main Results:
- Calcium overload significantly contributes to the development of adynamic bone disease.
- Alleviating calcium load with sevelamer hydrochloride shows potential therapeutic benefits.
Conclusions:
- Targeting calcium overload is crucial for adynamic bone disease management.
- Sevelamer hydrochloride and appropriate vitamin D administration may be effective for ABD prevention and treatment.